Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.
2.

Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.

Schild S, Nelson EJ, Bishop AL, Camilli A.

Infect Immun. 2009 Jan;77(1):472-84. doi: 10.1128/IAI.01139-08.

3.

Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Schild S, Nelson EJ, Camilli A.

Infect Immun. 2008 Oct;76(10):4554-63. doi: 10.1128/IAI.00532-08.

4.

Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.

Roy N, Barman S, Ghosh A, Pal A, Chakraborty K, Das SS, Saha DR, Yamasaki S, Koley H.

FEMS Immunol Med Microbiol. 2010 Oct;60(1):18-27. doi: 10.1111/j.1574-695X.2010.00692.x.

5.

Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission.

Bishop AL, Tarique AA, Patimalla B, Calderwood SB, Qadri F, Camilli A.

J Infect Dis. 2012 Feb 1;205(3):412-21. doi: 10.1093/infdis/jir756.

6.

Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.

Lebens M, Karlsson SL, Källgård S, Blomquist M, Ekman A, Nygren E, Holmgren J.

Vaccine. 2011 Oct 6;29(43):7505-13. doi: 10.1016/j.vaccine.2011.06.121.

PMID:
21807059
7.

Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.

Leitner DR, Feichter S, Schild-Prüfert K, Rechberger GN, Reidl J, Schild S.

Infect Immun. 2013 Jul;81(7):2379-93. doi: 10.1128/IAI.01382-12.

8.

Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.

Tarique AA, Kalsy A, Arifuzzaman M, Rollins SM, Charles RC, Leung DT, Harris JB, Larocque RC, Sheikh A, Bhuiyan MS, Saksena R, Clements JD, Calderwood SB, Qadri F, Kovác P, Ryan ET.

Clin Vaccine Immunol. 2012 Apr;19(4):594-602. doi: 10.1128/CVI.05689-11.

9.

Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.

Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.

Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041.

PMID:
19146897
10.

Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.

Villeneuve S, Boutonnier A, Mulard LA, Fournier JM.

Microbiology. 1999 Sep;145 ( Pt 9):2477-84.

PMID:
10517600
11.
12.

[The excretion pattern and protective capacity in rabbits orally immunized with attenuated strains of Vibrio cholerae O1 biotype El Tor].

García Sánchez HM, García Imia L, Oliva Hernández R, Pérez Quiñoy JL, Cedré Marrero B, Domínguez Iriarte R, Benítez Robles J.

Rev Cubana Med Trop. 1998;50(2):115-9. Spanish.

PMID:
10349429
13.

Differentiation among the Vibrio cholerae serotypes O1, O139, O141 and non-O1, non-O139, non-O141 using specific monoclonal antibodies with dot blotting.

Pengsuk C, Longyant S, Rukpratanporn S, Chaivisuthangkura P, Sridulyakul P, Sithigorngul P.

J Microbiol Methods. 2011 Nov;87(2):224-33. doi: 10.1016/j.mimet.2011.07.022.

PMID:
21851839
14.
15.

A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.

Sayeed MA, Bufano MK, Xu P, Eckhoff G, Charles RC, Alam MM, Sultana T, Rashu MR, Berger A, Gonzalez-Escobedo G, Mandlik A, Bhuiyan TR, Leung DT, LaRocque RC, Harris JB, Calderwood SB, Qadri F, Vann WF, Kováč P, Ryan ET.

PLoS Negl Trop Dis. 2015 Jul 8;9(7):e0003881. doi: 10.1371/journal.pntd.0003881.

16.

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.

Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, Khan AI, Khan IA, Clemens J, Ali M, Cravioto A, Qadri F.

Vaccine. 2011 Oct 26;29(46):8285-92. doi: 10.1016/j.vaccine.2011.08.108.

PMID:
21907255
17.

Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.

Kundu J, Mazumder R, Srivastava R, Srivastava BS.

FEMS Immunol Med Microbiol. 2009 Jul;56(2):179-84. doi: 10.1111/j.1574-695X.2009.00563.x.

19.

Pentavalent outer membrane vesicles of Vibrio cholerae induce adaptive immune response and protective efficacy in both adult and passive suckling mice models.

Sinha R, Koley H, Nag D, Mitra S, Mukhopadhyay AK, Chattopadhyay B.

Microbes Infect. 2015 Mar;17(3):215-27. doi: 10.1016/j.micinf.2014.10.011.

PMID:
25461799
20.

[Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens].

Smirnova NI, Livanova LF, Chekhovskaia GV, Eroshenko GA, Lazovskiĭ IuV, Zakharova TL.

Zh Mikrobiol Epidemiol Immunobiol. 2000 May-Jun;(3):47-51. Russian.

PMID:
10925874
Items per page

Supplemental Content

Support Center